Luyan PharmaLtd Balance Sheet Health
Financial Health criteria checks 4/6
Luyan PharmaLtd has a total shareholder equity of CN¥3.1B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 161.7%. Its total assets and total liabilities are CN¥12.4B and CN¥9.3B respectively. Luyan PharmaLtd's EBIT is CN¥705.6M making its interest coverage ratio 3.2. It has cash and short-term investments of CN¥481.5M.
Key information
161.7%
Debt to equity ratio
CN¥5.01b
Debt
| Interest coverage ratio | 3.2x |
| Cash | CN¥481.54m |
| Equity | CN¥3.10b |
| Total liabilities | CN¥9.30b |
| Total assets | CN¥12.40b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002788's short term assets (CN¥9.7B) exceed its short term liabilities (CN¥8.4B).
Long Term Liabilities: 002788's short term assets (CN¥9.7B) exceed its long term liabilities (CN¥868.5M).
Debt to Equity History and Analysis
Debt Level: 002788's net debt to equity ratio (146.1%) is considered high.
Reducing Debt: 002788's debt to equity ratio has reduced from 176.7% to 161.7% over the past 5 years.
Debt Coverage: 002788's debt is not well covered by operating cash flow (17.3%).
Interest Coverage: 002788's interest payments on its debt are well covered by EBIT (3.2x coverage).